| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heteroptera | 5 | 2024 | 14 | 3.380 |
Why?
|
| Nanoparticles | 10 | 2024 | 586 | 2.700 |
Why?
|
| Mammary Glands, Animal | 9 | 2023 | 635 | 2.060 |
Why?
|
| Phylogeny | 5 | 2024 | 867 | 1.310 |
Why?
|
| Metal Nanoparticles | 4 | 2024 | 160 | 1.210 |
Why?
|
| Phylogeography | 2 | 2024 | 18 | 1.180 |
Why?
|
| Climate Change | 2 | 2024 | 40 | 1.130 |
Why?
|
| Mammary Neoplasms, Experimental | 5 | 2023 | 557 | 1.100 |
Why?
|
| Biodiversity | 1 | 2024 | 93 | 0.920 |
Why?
|
| Dopaminergic Neurons | 1 | 2024 | 54 | 0.900 |
Why?
|
| Nanostructures | 3 | 2020 | 101 | 0.900 |
Why?
|
| Hemiptera | 1 | 2023 | 10 | 0.900 |
Why?
|
| Cerium | 2 | 2024 | 3 | 0.890 |
Why?
|
| Wound Infection | 1 | 2022 | 66 | 0.820 |
Why?
|
| Genome, Mitochondrial | 1 | 2022 | 40 | 0.800 |
Why?
|
| Mammary Neoplasms, Animal | 4 | 2018 | 237 | 0.800 |
Why?
|
| Genetic Vectors | 4 | 2020 | 1884 | 0.800 |
Why?
|
| Gadolinium | 3 | 2020 | 172 | 0.790 |
Why?
|
| Cranial Irradiation | 1 | 2024 | 322 | 0.790 |
Why?
|
| Animals | 46 | 2024 | 62801 | 0.780 |
Why?
|
| Epithelial Cells | 8 | 2024 | 1887 | 0.760 |
Why?
|
| Chlorine | 1 | 2020 | 16 | 0.740 |
Why?
|
| Stem Cells | 4 | 2021 | 1231 | 0.730 |
Why?
|
| Free Radicals | 1 | 2020 | 64 | 0.730 |
Why?
|
| Gene Editing | 1 | 2023 | 231 | 0.730 |
Why?
|
| Photosensitizing Agents | 1 | 2020 | 81 | 0.710 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 2989 | 0.700 |
Why?
|
| Energy Transfer | 1 | 2019 | 36 | 0.700 |
Why?
|
| Thermography | 1 | 2020 | 57 | 0.690 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 7922 | 0.690 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2019 | 8 | 0.680 |
Why?
|
| Glutathione | 3 | 2023 | 377 | 0.670 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2018 | 148 | 0.660 |
Why?
|
| Carcinogenesis | 6 | 2021 | 1031 | 0.650 |
Why?
|
| Lentivirus | 5 | 2020 | 167 | 0.640 |
Why?
|
| Precancerous Conditions | 3 | 2023 | 1066 | 0.630 |
Why?
|
| Insecta | 2 | 2022 | 88 | 0.620 |
Why?
|
| Wnt Signaling Pathway | 3 | 2021 | 443 | 0.610 |
Why?
|
| Mice | 33 | 2024 | 36026 | 0.610 |
Why?
|
| Neoplasms | 6 | 2024 | 15852 | 0.590 |
Why?
|
| Spinal Cord Injuries | 1 | 2020 | 350 | 0.570 |
Why?
|
| Oxygen | 2 | 2018 | 799 | 0.570 |
Why?
|
| Keratin-6 | 4 | 2016 | 40 | 0.560 |
Why?
|
| Oncogenes | 4 | 2024 | 700 | 0.550 |
Why?
|
| DNA Helicases | 1 | 2019 | 449 | 0.550 |
Why?
|
| Transfection | 2 | 2020 | 3169 | 0.520 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2018 | 2471 | 0.510 |
Why?
|
| RNA, Ribosomal | 2 | 2012 | 94 | 0.490 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 618 | 0.440 |
Why?
|
| Gene Transfer Techniques | 2 | 2023 | 812 | 0.440 |
Why?
|
| Breast Neoplasms | 12 | 2021 | 16193 | 0.440 |
Why?
|
| China | 3 | 2024 | 642 | 0.440 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 2013 | 11 | 0.440 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 7465 | 0.430 |
Why?
|
| DNA, Mitochondrial | 2 | 2024 | 313 | 0.410 |
Why?
|
| Archaea | 1 | 2012 | 19 | 0.410 |
Why?
|
| Eukaryota | 1 | 2012 | 28 | 0.400 |
Why?
|
| Nuclear Proteins | 3 | 2023 | 3460 | 0.390 |
Why?
|
| Wnt Proteins | 1 | 2013 | 391 | 0.390 |
Why?
|
| Ribosomes | 1 | 2012 | 170 | 0.380 |
Why?
|
| Mice, Transgenic | 9 | 2023 | 4373 | 0.360 |
Why?
|
| Receptor, ErbB-2 | 5 | 2016 | 2648 | 0.360 |
Why?
|
| Retroviridae | 3 | 2023 | 376 | 0.340 |
Why?
|
| Silicon Dioxide | 3 | 2020 | 52 | 0.330 |
Why?
|
| Cell Nucleus | 2 | 2024 | 1742 | 0.310 |
Why?
|
| Protein Array Analysis | 2 | 2022 | 505 | 0.300 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 791 | 0.290 |
Why?
|
| Bayes Theorem | 3 | 2022 | 1038 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2020 | 9083 | 0.290 |
Why?
|
| Cell Plasticity | 2 | 2017 | 66 | 0.260 |
Why?
|
| Skin Neoplasms | 2 | 2020 | 4835 | 0.260 |
Why?
|
| Antineoplastic Agents | 6 | 2020 | 14679 | 0.240 |
Why?
|
| Transcription Factors | 1 | 2019 | 5493 | 0.240 |
Why?
|
| Animal Distribution | 1 | 2024 | 10 | 0.240 |
Why?
|
| Diffusion | 1 | 2024 | 96 | 0.230 |
Why?
|
| Benzopyrans | 1 | 2024 | 43 | 0.230 |
Why?
|
| Genes, Reporter | 4 | 2020 | 831 | 0.230 |
Why?
|
| Rats | 2 | 2024 | 6639 | 0.220 |
Why?
|
| Peptidoglycan | 1 | 2022 | 21 | 0.220 |
Why?
|
| Boron | 1 | 2022 | 12 | 0.220 |
Why?
|
| Hydrogen Peroxide | 3 | 2023 | 225 | 0.210 |
Why?
|
| Recombinational DNA Repair | 1 | 2023 | 78 | 0.210 |
Why?
|
| beta Catenin | 3 | 2023 | 690 | 0.210 |
Why?
|
| Surface Properties | 2 | 2020 | 187 | 0.210 |
Why?
|
| Particle Size | 2 | 2020 | 187 | 0.210 |
Why?
|
| Biological Evolution | 1 | 2024 | 286 | 0.210 |
Why?
|
| Polyethylene Glycols | 2 | 2018 | 642 | 0.210 |
Why?
|
| India | 1 | 2023 | 314 | 0.210 |
Why?
|
| Neoptera | 1 | 2022 | 1 | 0.210 |
Why?
|
| Boron Compounds | 1 | 2022 | 69 | 0.210 |
Why?
|
| Proteogenomics | 1 | 2023 | 109 | 0.210 |
Why?
|
| Microbubbles | 1 | 2022 | 17 | 0.210 |
Why?
|
| CD40 Ligand | 1 | 2022 | 130 | 0.200 |
Why?
|
| Cell Line, Tumor | 13 | 2023 | 14875 | 0.200 |
Why?
|
| Acoustics | 1 | 2022 | 40 | 0.200 |
Why?
|
| Janus Kinase 2 | 2 | 2018 | 754 | 0.200 |
Why?
|
| Melanoma | 1 | 2019 | 5525 | 0.200 |
Why?
|
| Female | 29 | 2023 | 148456 | 0.200 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2019 | 1004 | 0.200 |
Why?
|
| Electric Impedance | 1 | 2022 | 101 | 0.190 |
Why?
|
| Nucleic Acid Conformation | 2 | 2013 | 306 | 0.190 |
Why?
|
| Rats, Transgenic | 1 | 2020 | 19 | 0.190 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 573 | 0.190 |
Why?
|
| Temperature | 2 | 2020 | 542 | 0.190 |
Why?
|
| Drug Carriers | 2 | 2023 | 336 | 0.190 |
Why?
|
| Neuroprotection | 1 | 2020 | 21 | 0.180 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 532 | 0.180 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2020 | 23 | 0.180 |
Why?
|
| Silver | 1 | 2020 | 39 | 0.180 |
Why?
|
| Infrared Rays | 1 | 2020 | 62 | 0.180 |
Why?
|
| Action Potentials | 1 | 2024 | 596 | 0.180 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 82 | 0.180 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 68 | 0.180 |
Why?
|
| Sodium Fluoride | 1 | 2020 | 34 | 0.180 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 593 | 0.180 |
Why?
|
| Cell Survival | 4 | 2020 | 3081 | 0.170 |
Why?
|
| CRISPR-Cas Systems | 1 | 2023 | 352 | 0.170 |
Why?
|
| STAT5 Transcription Factor | 2 | 2018 | 227 | 0.170 |
Why?
|
| Bismuth | 1 | 2020 | 101 | 0.170 |
Why?
|
| Theranostic Nanomedicine | 2 | 2017 | 15 | 0.170 |
Why?
|
| Metformin | 1 | 2023 | 395 | 0.170 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 11775 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 3169 | 0.160 |
Why?
|
| Spine | 1 | 2020 | 311 | 0.160 |
Why?
|
| Cell Proliferation | 8 | 2020 | 7302 | 0.160 |
Why?
|
| Juglandaceae | 1 | 2018 | 1 | 0.160 |
Why?
|
| A549 Cells | 1 | 2018 | 127 | 0.160 |
Why?
|
| Wnt1 Protein | 1 | 2018 | 102 | 0.160 |
Why?
|
| Thiazoles | 1 | 2023 | 729 | 0.160 |
Why?
|
| Models, Genetic | 2 | 2013 | 1079 | 0.160 |
Why?
|
| Diptera | 1 | 2018 | 28 | 0.160 |
Why?
|
| Plasmids | 1 | 2020 | 952 | 0.160 |
Why?
|
| HEK293 Cells | 2 | 2020 | 1473 | 0.150 |
Why?
|
| Sepsis | 1 | 2024 | 688 | 0.150 |
Why?
|
| Bacteria | 1 | 2022 | 650 | 0.150 |
Why?
|
| Humans | 28 | 2023 | 270825 | 0.150 |
Why?
|
| Computational Biology | 3 | 2014 | 1263 | 0.150 |
Why?
|
| Magnetic Fields | 1 | 2018 | 33 | 0.150 |
Why?
|
| Cysteine | 1 | 2018 | 214 | 0.150 |
Why?
|
| Wound Healing | 1 | 2022 | 755 | 0.150 |
Why?
|
| Electrochemical Techniques | 1 | 2017 | 8 | 0.150 |
Why?
|
| Copper | 1 | 2018 | 166 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 337 | 0.150 |
Why?
|
| Naphthoquinones | 1 | 2017 | 19 | 0.150 |
Why?
|
| Adenoviridae | 1 | 2023 | 1510 | 0.150 |
Why?
|
| Spleen | 1 | 2019 | 735 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 614 | 0.140 |
Why?
|
| Twist-Related Protein 1 | 1 | 2017 | 132 | 0.140 |
Why?
|
| Recovery of Function | 1 | 2020 | 691 | 0.140 |
Why?
|
| Biosensing Techniques | 1 | 2017 | 82 | 0.140 |
Why?
|
| Mitochondria | 1 | 2024 | 1318 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 1 | 2024 | 2561 | 0.140 |
Why?
|
| Iron Compounds | 1 | 2016 | 3 | 0.130 |
Why?
|
| Receptors, Estrogen | 2 | 2021 | 2264 | 0.130 |
Why?
|
| Inflammation | 2 | 2024 | 2526 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 2 | 2014 | 1469 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2024 | 2089 | 0.130 |
Why?
|
| Hyperthermia, Induced | 2 | 2018 | 510 | 0.130 |
Why?
|
| Base Sequence | 2 | 2013 | 5494 | 0.130 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 205 | 0.130 |
Why?
|
| X-Rays | 1 | 2015 | 153 | 0.120 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 6784 | 0.120 |
Why?
|
| Histones | 1 | 2022 | 1513 | 0.120 |
Why?
|
| Claudins | 1 | 2014 | 56 | 0.120 |
Why?
|
| Cell Movement | 2 | 2019 | 2502 | 0.120 |
Why?
|
| Tungsten Compounds | 1 | 2013 | 3 | 0.120 |
Why?
|
| Ischemia | 1 | 2017 | 403 | 0.120 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2014 | 22 | 0.120 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 185 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2020 | 1157 | 0.110 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 1380 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 4067 | 0.110 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 1011 | 0.110 |
Why?
|
| Phototherapy | 1 | 2013 | 82 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 4 | 2021 | 2474 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 340 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2014 | 239 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 531 | 0.110 |
Why?
|
| DNA, Ribosomal | 1 | 2013 | 105 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 5042 | 0.110 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2012 | 34 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 178 | 0.100 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 896 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 4326 | 0.100 |
Why?
|
| Iron | 1 | 2016 | 379 | 0.100 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2012 | 23 | 0.100 |
Why?
|
| Peptidyl Transferases | 1 | 2012 | 7 | 0.100 |
Why?
|
| Nanotechnology | 1 | 2013 | 137 | 0.100 |
Why?
|
| Contig Mapping | 1 | 2012 | 63 | 0.100 |
Why?
|
| Thyroid Hormones | 1 | 2012 | 113 | 0.100 |
Why?
|
| Base Pairing | 1 | 2012 | 69 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2018 | 5780 | 0.100 |
Why?
|
| Avian Leukosis Virus | 1 | 2011 | 15 | 0.100 |
Why?
|
| Likelihood Functions | 1 | 2012 | 221 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2015 | 664 | 0.100 |
Why?
|
| Conserved Sequence | 1 | 2013 | 498 | 0.100 |
Why?
|
| Molecular Imaging | 1 | 2013 | 187 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 2617 | 0.090 |
Why?
|
| Sequence Alignment | 1 | 2013 | 884 | 0.090 |
Why?
|
| Gene Amplification | 1 | 2014 | 769 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2018 | 4190 | 0.090 |
Why?
|
| Liver | 1 | 2019 | 3123 | 0.080 |
Why?
|
| Oxidation-Reduction | 2 | 2023 | 718 | 0.080 |
Why?
|
| Signal Transduction | 6 | 2020 | 12206 | 0.080 |
Why?
|
| Phosphorylation | 4 | 2024 | 4990 | 0.080 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 697 | 0.080 |
Why?
|
| Mice, Nude | 4 | 2018 | 4360 | 0.080 |
Why?
|
| I-kappa B Kinase | 2 | 2024 | 250 | 0.080 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2008 | 154 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 687 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 1146 | 0.070 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 865 | 0.070 |
Why?
|
| Apoptosis | 6 | 2021 | 7853 | 0.070 |
Why?
|
| Binding Sites | 1 | 2012 | 2306 | 0.070 |
Why?
|
| Chromatin | 2 | 2023 | 1050 | 0.070 |
Why?
|
| Neoplasm Transplantation | 3 | 2014 | 1567 | 0.070 |
Why?
|
| Cisplatin | 1 | 2013 | 2493 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 3661 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2012 | 1584 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2017 | 623 | 0.060 |
Why?
|
| Escherichia coli | 1 | 2012 | 1308 | 0.060 |
Why?
|
| Keratins | 1 | 2006 | 352 | 0.060 |
Why?
|
| Software | 1 | 2012 | 1360 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 2667 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 5567 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2012 | 2123 | 0.060 |
Why?
|
| Brain | 1 | 2017 | 4245 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2012 | 2379 | 0.060 |
Why?
|
| Polyphenols | 1 | 2023 | 30 | 0.060 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 1372 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2018 | 1855 | 0.050 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2023 | 117 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 704 | 0.050 |
Why?
|
| Electrons | 1 | 2023 | 187 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2012 | 1777 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2012 | 2958 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 1884 | 0.050 |
Why?
|
| DNA Damage | 1 | 2010 | 1980 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 3657 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2023 | 581 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2014 | 402 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 2125 | 0.050 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 531 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 4789 | 0.050 |
Why?
|
| Ubiquitination | 2 | 2013 | 577 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 170 | 0.040 |
Why?
|
| Hydroxyl Radical | 1 | 2018 | 21 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2017 | 5835 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 5427 | 0.040 |
Why?
|
| Carya | 1 | 2018 | 1 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 623 | 0.040 |
Why?
|
| Pimozide | 1 | 2018 | 8 | 0.040 |
Why?
|
| Doxorubicin | 2 | 2018 | 3138 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 1011 | 0.040 |
Why?
|
| Hyperprolactinemia | 1 | 2018 | 20 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 153 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 3929 | 0.040 |
Why?
|
| Time Factors | 1 | 2012 | 13103 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 588 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2022 | 816 | 0.040 |
Why?
|
| Risperidone | 1 | 2018 | 62 | 0.040 |
Why?
|
| Luminescent Agents | 1 | 2017 | 18 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2020 | 401 | 0.040 |
Why?
|
| Ferric Compounds | 1 | 2018 | 77 | 0.040 |
Why?
|
| Osteocytes | 1 | 2017 | 35 | 0.040 |
Why?
|
| Male | 4 | 2021 | 128398 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 191 | 0.040 |
Why?
|
| Intestines | 1 | 2021 | 730 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 911 | 0.030 |
Why?
|
| Glass | 1 | 2016 | 33 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2017 | 159 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 2093 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 7936 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 4980 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2015 | 76 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 1547 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 1132 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 1436 | 0.030 |
Why?
|
| Virus Latency | 1 | 2015 | 79 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 38 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 553 | 0.030 |
Why?
|
| Fluorescence | 1 | 2014 | 201 | 0.030 |
Why?
|
| Virion | 1 | 2015 | 187 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 61 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 217 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 432 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 1206 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 255 | 0.030 |
Why?
|
| Materials Testing | 1 | 2013 | 119 | 0.030 |
Why?
|
| Organosilicon Compounds | 1 | 2013 | 3 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2013 | 45 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2013 | 32 | 0.030 |
Why?
|
| Colloids | 1 | 2013 | 36 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 3246 | 0.030 |
Why?
|
| Porosity | 1 | 2013 | 56 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 662 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 214 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 352 | 0.030 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2012 | 34 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 2012 | 59 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2012 | 50 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 496 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2013 | 191 | 0.030 |
Why?
|
| Adult | 1 | 2019 | 81540 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 680 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2015 | 706 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 186 | 0.030 |
Why?
|
| Middle Aged | 1 | 2019 | 90030 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 672 | 0.020 |
Why?
|
| Heterografts | 1 | 2014 | 745 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2013 | 358 | 0.020 |
Why?
|
| Etoposide | 1 | 2014 | 905 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2012 | 643 | 0.020 |
Why?
|
| Breast | 1 | 2018 | 1379 | 0.020 |
Why?
|
| Serine | 1 | 2012 | 396 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 312 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 445 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1084 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 1719 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 7220 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2020 | 2743 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 534 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 704 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2014 | 1985 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 1834 | 0.020 |
Why?
|
| Keratin-9 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Disease Progression | 1 | 2020 | 6892 | 0.020 |
Why?
|
| Alpharetrovirus | 1 | 2008 | 7 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 13361 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 1398 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 2312 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 1617 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 2008 | 174 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 260 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 1820 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2010 | 435 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2010 | 390 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 5103 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2014 | 1669 | 0.020 |
Why?
|
| HIV | 1 | 2008 | 237 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 1249 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 2466 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 9040 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 5435 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 3226 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2006 | 356 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 6185 | 0.010 |
Why?
|
| Mutation | 2 | 2016 | 15859 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 17814 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 1524 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 7782 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 22452 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 5163 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 33821 | 0.010 |
Why?
|